Skip to content

Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity

Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07715409
Enrollment
600
Registered
2026-07-20
Start date
2027-05-01
Completion date
2027-05-01
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Endometritis, Surgical Site Infection

Brief summary

This randomized controlled trial aims to evaluate the efficacy of preoperative vaginal cleansing with 5% povidone-iodine in reducing postoperative infectious morbidity among women undergoing cesarean section. The primary outcomes include wound-related complications, while secondary outcomes include postoperative fever, endometritis, wound infection, and white blood cell count.

Interventions

Vaginal cleansing with 5% povidone-iodine for 30 seconds before cesarean section.

Sponsors

Mohamed Mousa Mohamed Mousa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

\- Women undergoing elective or emergency cesarean section. Received prophylactic antibiotics before surgery

Exclusion criteria

* Active infection No prophylactic antibiotics Chorioamnionitis Placenta previa with antepartum hemorrhage

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative wound-related complications Time Frame: Within 8 weeks after cesarean section8 weeks
Incidence of postoperative wound-related complicationsWithin 8 weeks after cesarean section

Secondary

MeasureTime frame
Postoperative fever (within 8 weeks) Postoperative WBC count (24 hours) Endometritis (within 8 weeks) Combined wound complications and endometritis8 weeks

Countries

Egypt

Contacts

CONTACTmohamed mousa Al-Azhar University Hospital, Damietta
mohamed.mousa.k0109@gmail.com2001021267963
CONTACTmohamed mousa mohamed
STUDY_DIRECTORahmed shafik ibrahim

abdelrouf

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026